99. 慢性特発性偽性腸閉塞症 ［臨床試験数：2，薬物数：6（DrugBank：1），標的遺伝子数：0，標的パスウェイ数：0］
Searched query = "Chronic intestinal pseudo obstruction", "Chronic idiopathic pseudo bowel obstruction"
The queries were searched in Public_title, Scientific_title, and Condition of the data. Export date: 11/20/2019, 11/21/2019. Trials are sorted by Date_enrolment from most recent to oldest in the table.
| No. | TrialID | Date_ enrollement | Last_Refreshed_ on | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT04118699 | November 1, 2019 | 11 November 2019 | Efficacy and Safety of Rifaximin for Patients With Chronic Intestinal Pseudo-obstruction: a Phase 2 Trial | Efficacy and Safety of Rifaximin for Patients With Chronic Intestinal Pseudo-obstruction: a Single Center, Randomized, Placebo Controlled, Double-blind Phase 2 Trial | Chronic Intestinal Pseudo-obstruction | Drug: Rifaximin oral tablet;Drug: Placebo oral tablet | Yokohama City University | ASKA Pharmaceutical Co., Ltd. | Recruiting | 20 Years | 74 Years | All | 12 | Phase 2 | Japan |
| 2 | NCT00793247 | December 2008 | 19 February 2015 | Efficacy Study of Prucalopride to Treat Chronic Intestinal Pseudo-Obstruction (CIP) | A Double-Blind, Placebo-Controlled, Cross-Over, Multiple (n=1) Trial to Evaluate the Effects of R093877 in Patients With Chronic Intestinal Pseudo-Obstruction (CIP). | Chronic Intestinal Pseudo-Obstruction | Drug: PRU-PLA-PRU-PLA;Drug: PLA-PRU-PLA-PRU;Drug: PLA-PRU-PRU-PLA;Drug: PRU-PLA-PLA-PRU | Movetis | Not recruiting | 18 Years | N/A | Both | Phase 2 | United Kingdom |